SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ed Ajootian who wrote (18)2/28/1998 12:49:00 AM
From: tnsaf  Read Replies (1) of 362
 
1996 prospectus, form SB-2 which is available at www.sec.gov, has the information below. The prospectus is interesting reading, because the company is/was a group of five operating companies.

Jason

Each Warrant currently entitles the registered holder thereof to purchase one share of Common Stock at $6.20 through January 18, 2001. The exercise price of the Warrants is subject to adjustment. Commencing January 18, 1997, the Warrants are subject to redemption by the Company at $.05 per Warrant on 30 days' prior written notice if the closing bid price of the Common Stock averages in excess of $9.10 per share for 30 consecutive business days ending within 15 days of the date of notice of redemption. See "Description of Securities." As of November 22, 1996, 54,100 Warrants had been exercised.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News